(19)
(11) EP 1 794 150 A1

(12)

(43) Date of publication:
13.06.2007 Bulletin 2007/24

(21) Application number: 05786524.8

(22) Date of filing: 22.09.2005
(51) International Patent Classification (IPC): 
C07D 405/06(2006.01)
A61P 1/00(2006.01)
A61P 25/16(2006.01)
A61P 25/28(2006.01)
A61P 9/00(2006.01)
A61K 31/4184(2006.01)
A61P 25/00(2006.01)
A61P 25/22(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/SE2005/001404
(87) International publication number:
WO 2006/033632 (30.03.2006 Gazette 2006/13)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 24.09.2004 WO PCT/GB2004/004112
24.09.2004 WO PCT/GB2004/004126
30.12.2004 US 640309 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • LIU, Ziping, AstraZeneca R & D Montreal
    St. Laurent, Québec H4S 1Z9 (CA)
  • PAGÈ, Daniel, AstraZeneca R & D Montreal
    St. Laurent, Québec H4S 1Z9 (CA)
  • TREMBLAY, Maxime, AstraZeneca R & D Montreal
    St. Laurent, Québec H4S 1Z9 (CA)
  • WALPOLE, Christopher, AstraZeneca R & D Montreal
    St. Laurent, Québec H4S 1Z9 (CA)
  • YANG, Hua, AstraZeneca R & D Montreal
    St. Laurent, Québec H4S 1Z9 (CA)

(74) Representative: Wahlström, Stig Christer Gunnar et al
AstraZeneca Global Intellectual Property
151 85 Södertälje
151 85 Södertälje (SE)

   


(54) Benzimidazole derivatives and their use as cannabinoid receptor ligands I